已收盘 02-06 16:00:00 美东时间
+0.940
+8.03%
Prestige Consumer Q3 revenue slightly beats expectations Overview Consumer healthcare firm's Q3 revenue slightly beat analyst expectations Adjusted EPS for Q3 met analyst expectations Company closed acquisition of Pillar5 Pharma and repurchased 0.8 mln shares Outlook Prestige narrows fiscal 2026 rev
02-05 19:10
UPDATE 2-Wegovy-maker Novo Nordisk warns of 'unprecedented' price pressure as shares tumble Novo forecasts profit and sales to fall as much as 13% in 2026 Analysts had expected 2% decline on average Novo competes with Eli Lilly in lucrative obesity drug market Market faces price pressures, rising co
02-04 15:16
Novo Nordisk's shock 2026 guidance points to obesity battle heating up Novo forecasts profit and sales to fall as much as 13% in 2026 Analysts had expected 2% decline on average Novo competes with Eli Lilly in lucrative obesity drug market Market faces price pressures, rising competition By Maggie F
02-04 14:40
BRIEF-Allied Gaming & Entertainment Says Shareholders Approve Advisory Proposal Related To Shareholder Rights Plan (Poison Pill) Feb 2 (Reuters) - Allied Gaming & Entertainment Inc AGAE.O : ALLIED GAMING & ENTERTAINMENT SHAREHOLDERS APPROVE ADVISORY PROPOSAL RELATED TO SHAREHOLDER RIGHTS PLAN (POISO
02-03 12:04
UPDATE 3-Novo's Wegovy pill hits over 18,000 US prescriptions in strong debut week Wegovy launch impressive versus previous GLP-1 launches, analysts say Pill prescribed 18,410 times in the week ended January 16 FDA decision on Lilly's pill expected by April Adds analyst comment in paragraph 4 By Sri
01-23 20:47
Trump's "Great Healthcare Plan" targets PBM kickbacks to cut costs. Experts confirm these fees act as an industry "vig" driving up prices.
01-16 15:30
Nippon Pillar Packing Co., Ltd. ( ($JP:6490) ) just unveiled an announcement. P...
2025-12-03 14:22
President Donald Trump's proposed 100% tariffs on foreign pharmaceuticals will ultimately be paid by American patients and insurers, not foreign drug companies, according to economist Justin Wolfers.
2025-09-29 15:20
Mark Cuban explains how PBMs & wholesalers force pharmacies into exclusive deals, creating a 'stranglehold' on prescription drug prices.
2025-09-08 13:49
Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for innovation.
2025-08-01 16:12